EU medical agency recommends emergency use authorization for Moderna vaccine
The European Medicines Agency has recommended granting a conditional marketing authorization for Moderna's COVID-19 vaccine for people who are at least 18 years old.
This is the second vaccine the EMA has recommended for authorization. The Pfizer/BioNTech vaccine was approved by the EU in December.
The EMA cited a large clinical trial, involving around 30,000 people, that showed a 94.1% efficacy rate.
“This vaccine provides us with another tool to overcome the current emergency,” said Emer Cooke, executive director of EMA. “It is a testament to the efforts and commitment of all involved that we have this second positive vaccine recommendation just short of a year since the pandemic was declared by WHO.
The European Commission must give final approval of the conditional marketing authorization in order for the vaccine to be distributed, but that appears to be a formality.
-ABC News' Christine Theodorou contributed to this report.